Posted by MB on July 3, 2003, at 21:36:54
In reply to Re: Nice to see...thank you, posted by Jack Smith on July 1, 2003, at 17:54:09
> I agree but notice that only the seratonin/norepinephrine drugs are in late stage trials. Fact is that they still have not been able to develop an effective AD that does not concentrate on seratonin, NE and to a lesser extent dopamine. I hope they will soon.
>
> JACKWait, there is a tachykinin receptor (NK-1) antagonist, a glucocorticoid receptor antagonist, and a peptide ligand in phase III. That's not too bad is it?
MB
poster:MB
thread:238497
URL: http://www.dr-bob.org/babble/20030701/msgs/239090.html